|
 |
DynacinThis page contains recent news articles, when available, and an overview of Dynacin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Dynacin (when available) Minocycline, the most lipid soluble and most active tetracycline antibiotic, is, like doxycycline, a long-acting tetracycline. Minocycline's effects are related to the inhibition of protein synthesis. Minocycline is used to treat nongonococcal urethritis, mucopurulent cervicitis, acne vulgaris, and rheumatoid arthritis and some othet infections. Because of its lipid solubility, minocycline is able to eradicate the meningococcal carrier state in tears and saliva. For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by Rickettsiae, Upper respiratory tract infections caused by Streptococcus pneumoniee; For the treatment of asymptomatic carriers of Neisseria meningitidis Mechanism Of Action: Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30 S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis. News Articles on Minocycline Medicis to Present at Goldman Sachs Healthcare Conference - Jan 4, 2010 The Company's products include the brands DYSPORT(TM) (abobotulinumtoxinA) 300 Units for Injection, PERLANE(R), RESTYLANE(R), DYNACIN(R) (minocycline HCl ... CNNMoney.com (press release) Medicis Reports Third Quarter 2009 Financial Results - Nov 4, 2009 The Company's products include the brands DYSPORT(TM) (abobotulinumtoxinA) 300 Units for Injection, PERLANE(R), RESTYLANE(R), DYNACIN(R) (minocycline HCl ... CNNMoney.com (press release) Medicis Announces Third Quarter 2009 Conference Call and Webcast - Nov 2, 2009 The Company's products include the brands DYSPORT(TM) (abobotulinumtoxinA) 300 Units for Injection, PERLANE(R), RESTYLANE(R), DYNACIN(R) (minocycline HCl ... Reuters Medicis Pharmaceutical Corporation - Pharmaceuticals & Healthcare - Deals and ... - Nov 9, 2009 The company´s branded products for various therapeutic categories include, Dynacin, Loprox, Plexion, Solodyn, Triaz, Vanos and Ziana, Ammonul, Buphenyl, ... PR-Inside.com (Pressemitteilung) Dynacin Oral : User Ratings covering uses, effectiveness, interactions... - Jun 8, 2008 I was prescribed Dynacin to help with facial cysts, and while the cysts have for the most part disappeared or been minimized, by general complexion isn't ... WebMD Breakup of Inamed merger helps Medicis - Mar 16, 2006 The company said it continues to experience erosion in its Dynacin (oral antibiotic for acne) and Loprox (antifungal medication) franchises due to generic ... Bizjournals.com Medicis reports $88.5M loss: Scottsdale firm says payment, fee helped... - May 10, 2006 Shacknai chalked that up to an expected reduction in contract revenue and the rise of generic alternatives for Medicis core products Dynacin and Loprox. ... Free with registration - The Tribune - AccessMyLibrary.com Medicis Reports Second Quarter Fiscal 2005 Financial Results; 31% … - Jan 20, 2005 ..."Continued growth of RESTYLANE(R), LOPROX(R) Shampoo and DYNACIN(R) Tablets highlighted the quarter, along with the introduction of our innovative ... $4.95 - Business Wire - ECNext Medicis Reports December 2005 Financial Results - Mar 15, 2006 The Company continues to experience erosion in our DYNACIN(R) and LOPROX(R) franchises due to generic competition. The Company believes its future growth ... primezone.com MEDICIS REPORTS 2ND QTR FISCAL '05 NET REVENUE GROWTH OF … - Mar 1, 2005 ..."Continued growth of RESTYLANE(R), LOPROX(R) Shampoo and DYNACIN(R) Tablets highlighted the quarter, along with the introduction of our innovative ... Free with registration - Biotech Financial Reports - AccessMyLibrary.com FINAL TRANSCRIPT - May 21, 2008 Our early success was spurred by the introduction of Dynacin, our legacy brand in ... And Dynacin brought Medicis into profitability and beyond. ... $54.00 - Thomson StreetEvents - Alacra Store Merger and Acquisition Scenario - Jan 27, 2007 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Solodyn Extended Release Tablet (Minocycline HCl); Dynacin (Minocycline ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Feb 24, 2007 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Feb 10, 2007 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Solodyn Extended Release Tablet (Minocycline HCl); Dynacin (Minocycline ... $250.00 - Revere Reports - Revere Article: MEDICIS REPORTS 2ND QTR FISCAL '05 NET REVENUE … - Mar 1, 2005 ..."Continued growth of RESTYLANE(R), LOPROX(R) Shampoo and DYNACIN(R) Tablets highlighted the quarter, along with the introduction of our innovative ... Pay-Per-View - Biotech Financial Reports - HighBeam Research Merger and Acquisition Scenario - Sep 23, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 15, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 19, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Solodyn Extended Release Tablet (Minocycline HCl); Dynacin (Minocycline ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 14, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Solodyn Extended Release Tablet (Minocycline HCl); Dynacin (Minocycline ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 11, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 2, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Solodyn Extended Release Tablet (Minocycline HCl); Dynacin (Minocycline ... $250.00 - Revere Reports - Revere Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder. - Feb 18, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... Free with registration - Business Wire - AccessMyLibrary.com Merger and Acquisition Scenario - May 13, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 9, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds... - Sep 6, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... RedOrbit Medicis reports quarterly profit up but revenue down. | Article from... - Mar 16, 2006 A write-down of assets for Dynacin capsules and special charges paid out for ... While Dynacin, especially, suffered from the competition, Medicis' star ... Pay-Per-View - The Tribune - HighBeam Research Merger and Acquisition Scenario - Aug 16, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 20, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis Requests That Inamed Recommend Rejection of Allergan … - Nov 22, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... RedOrbit Merger and Acquisition Scenario - May 19, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 5, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Q1 2006 Medicis Earnings Conference Call - Part 2. - Nov 8, 2005 There should be no surprise in the fact that Loprox and Dynacin are hit by generic competitors. These are events that we forecast. We are not delighted with ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Merger and Acquisition Scenario - Jun 9, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jun 21, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis and BioMarin Reach Settlement. - Jan 12, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... Free with registration - Business Wire - AccessMyLibrary.com Medicis reports revenue down | Arizona Business, personal finance, … - Aug 3, 2006 The product should spur significant sales in the future, possibly stealing shares from the company's own core product Dynacin, Shacknai said. ... East Valley Tribune Merger and Acquisition Scenario - Jul 21, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 12, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 5, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 13, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis to Present at Merrill Lynch 16th Annual Global Pharmaceutical,... - Feb 7, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Sep 29, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 12, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jun 16, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis to Present at 23rd Annual JPMorgan Healthcare Conference. - Jan 6, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Jun 28, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis to Present at UBS Global Life Sciences Conference. - Sep 26, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Nov 3, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 12, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP … - May 8, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Merger and Acquisition Scenario - Aug 16, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis Announces Third Quarter Fiscal 2005 Conference Call and … - Apr 18, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Apr 7, 2007 Solodyn Extended Release Tablet (Minocycline HCl); Dynacin (Minocycline Hydrochloride). Antibacterial Agents/Retinoids. Therapeutics that treat acne by ... $250.00 - Revere Reports - Revere Ipsen to Grant Medicis Rights to Distribute and Promote Ipsen's... - Mar 13, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Merger and Acquisition Scenario - Jul 19, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 7, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis Announces Second Quarter Fiscal 2005 Conference Call and … - Jan 17, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Medicis to Present at Morgan Stanley 2006 Global Healthcare Unplugged... - Apr 28, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis Announces First Quarter 2006 Conference Call and Webcast - May 4, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis Reports Second Quarter 2006 Financial Results - Aug 2, 2006 SOLODYN(R) will replace DYNACIN(R) as a core brand in future quarters, beginning with the quarter ended September 30, 2006. ... primezone.com Medicis Reports First Quarter 2006 Financial Results - May 9, 2006 At the end of the March 2006 quarter, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R), PLEXION(R), RESTYLANE(R), TRIAZ(R) and VANOS(TM) ... primezone.com Medicis to Present at Deutsche Bank 31st Annual Health Care … - Apr 27, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis Announces Two Patents Issued for LOPROX Gel - Apr 12, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis Announces December 2005 Quarter-End Conference Call and … - Mar 10, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis Announces FDA Approval of Broader Indication for VANOS - Mar 2, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis to Present at 24th Annual JPMorgan Healthcare Conference - Jan 6, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... RedOrbit Medicis Declares Cash Dividend - Mar 15, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis to Present at Merrill Lynch 17th Annual Global Pharmaceutical,... - Feb 3, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... RedOrbit Medicis Announces Fiscal 2005 Fourth Quarter and Year-End … - Aug 30, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Dec 27, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 29, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 22, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 7, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis Announces FDA Approval of Its NDA for VANOS, a Patented … - Feb 14, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Jul 28, 2007 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Medicis Pharmaceutical Corp - Jun 19, 2006 ...patent products such as Dynacin, Triaz and Lo-. prox, as well as new competition to MRX's key. Restylane dermal filler. On the plus side, we see ... $35.00 - Stock Reports - Standard & Poor's Medicis Declares Cash Dividend. - Sep 14, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Medicis Declares Cash Dividend. - Jun 15, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Medicis Amends and Restates Shareholder Rights Agreement. - Aug 17, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Medicis Declares Cash Dividend. - Mar 16, 2005 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Jun 7, 2008 Plexion/Plexion TS/Plexion SCT (Sodium Sulfacetamide/Sulfur); Dynacin (Minocycline ... Dynacin (Minocycline Hydrochloride); Solodyn Extended Release Tablet ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 3, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 16, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 25, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 16, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 19, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Medicis offers 15 branded products, including DYNACIN (minocycline HCI), LOPROX (ciclopirox), OMNICEF (cefdinir), PLEXION (sodium sulfacetamide/sulfur), ... $250.00 - Revere Reports - Revere Medicis Has an Earnings Glow - Aug 20, 2007 Patheon manufactures the capsule form of Dynacin, and Par Pharmaceutical (PRX) manufactures the tablet form. Plexion and Triaz are manufactured by Contract ... BusinessWeek Medicis Shares Could Get Boost From Near-Term Catalysts - Mar 16, 2006 ...bled down inventory in the channel, possibly in anticipation of an upcoming launch of a new version of Dynacin," Trbovich wrote in a research report. ... Forbes Rheumatoid arthritis - Sep 18, 2008 Common DMARDs include hydroxychloroquine (Plaquenil), the gold compound auranofin (Ridaura), sulfasalazine (Azulfidine), minocycline (Dynacin, Minocin) and ... CNN International Medicis to Present At RBC Capital Markets Healthcare Conference - Dec 10, 2007 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), ... Bloomberg Medicis Declares Cash Dividend - Dec 12, 2007 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), ... Bloomberg What can I do about MRSA infections? - Jan 1, 2008 Bactrim, Septra), tetracyclines (doxycycline [Doryx, Monodox, Vibramycin] or minocycline [Dynacin, Minocin, Myrac]), and clindamycin (Cleocin). 1,3,8 ... Journal of the American Academy of... Medicis Pharmaceutical says plans to buy Inamed still good - Apr 21, 2005 But he said sales in all the company's core products, from acne medication Dynacin to Loprox, a treatment for skin infections, were up. ... East Valley Tribune Medicis reports profit up in quarter | Arizona Business, personal... - Sep 2, 2005 Meanwhile, Medicis core products from acne medicine Dynacin to cosmetic dermatology superstar Restylane keep Medicis in the forefront of the dermatology ... East Valley Tribune Medicis seeking more space | Arizona Business, personal finance, … - Jul 22, 2006 The country's leading independent dermatological products company, Medicis made its name in prescription products, such as the acne treatment Dynacin. ... East Valley Tribune Medicis making itself a new home in Scottsdale - Apr 13, 2007 ...giants and has established its dominance in dermatological drugs with such market leaders as Dynacin, Triaz, Omnicef, Vanos and new product Solodyn. ... East Valley Tribune Charlotte Observer, The (NC) - Feb 7, 2005 ...and podiatric conditions and aesthetics medicine, has selected JC Thomas Marketing Communications to develop brand names for its new Dynacin QD drug. ... $2.95 - Charlotte Observer - NewsBank Fundamental Review for Medicis Pharmaceutical Corp. - Mar 20, 2007 Medicis' prescription medications and doctor-dispensed products include DYNACIN (oral antibiotic for acne), TRIAZ (topical acne cream), ... Free with registration - M2 Presswire - AccessMyLibrary.com Netherlands Corporate News - Ipsen and Medicis Announce Acceptance … - May 19, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Reloxin Agreement Between Ipsen and Medicis Becomes Effective - Mar 20, 2006 The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), ... primezone.com Medicis and Revance Announce Strategic Collaboration - Dec 11, 2007 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), ... RedOrbit PRESS RELEASE: Hyperion Therapeutics Announces Senior … - Oct 4, 2007 ...dermatology (Dynacin®), respiratory (Azmacort®, Intal®, and Orapred®) and rare metabolic disorders (AMMONUL and BUPHENYL® (sodium phenylbutyrate)). ... FierceBiotech Bellwether Report.com Shows Interest in Medicis Pharmaceutical Corp. - Oct 18, 2006 Medicis' prescription medications and doctor-dispensed products include DYNACIN (oral antibiotic for acne), TRIAZ (topical acne cream), ... Free with registration - M2 Presswire - AccessMyLibrary.com Brand Names/Synonyms: Dynacin is also known by the following brand names and/or synonymsAlti-Minocycline; Apo-Minocycline; Arestin; BRN 3077644; CL 59806; DYNACIN; Dynacin; Gen-Minocycline; HSDB 3130; Klinomycin; MINOCYCLINE; Minociclina [Inn-Spanish]; Minocin; Minocyclin; Minocycline; Minocycline Hcl; Minocycline [Usan:Ban:Inn]; Minocyclinum [Inn-Latin]; Minocyn; Minomycin; Novo-Minocycline; Vectrin Drug Category: Dynacin is categorized under the following by the FDA: Anti-bacterial Agents; Tetracyclines; ATC:A01AB23; ATC:J01AA08 Dosage Forms: Capsules; Subgingival (sustained-release); IV Injection; Absorption: rapidly absorbed from the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4,4a,5,5a,6,12a-hexahydrotetracene-1,3,12-trione |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |